Search results for

Chew Kherk Ying and Sonia Ong of Wong & Partners assess important developments in licensing, R&D, tech transfer and IP commercialisation

The effect of the EU’s regulation on health claims in foods is only now becoming apparent. Producers may find they have to prove claims as extensively as pharmaceutical companies, say Audrey Horton and Mary Smillie

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449

On April 10 2007, the famous French luxury brand Louis Vuitton Malletier filed an action with the Beijing First Intermediate People's Court against Mr Wang, owner of design patent registration no 02367907.7, for his unauthorized copying of its trade marks: (Louis Vuitton's corresponding Chinese mark), and , and all registered in Class 18 in respect of, among others: travelling bags, women's handbags and shopping bags for application on bags, the subject matter of Wang's design patent registration. Wang's registered design patent consists of the shape of a handbag.

Saul Santoyo and Jose Luis Ramos-Zurita of Uhthoff Gomez Vega & Uhthoff chart the rise of the counterfeit industry from minor legal issue to global criminal network

Shwetasree Majumder and Harsimran Kalra of Fidus Law Chambers consider whether it’s time for a legislative overhaul to stop the ambush marketing of sporting events

Dr Malathi Lakshmikumaran and Badri Narayanan of Lakshmikumaran & Sridharan (L&S) consider the changing face of patent law

The Irish High Court has recently given a landmark decision concerning Council Regulation (EC) 6/2002 (the Regulation) which protects Community design rights. This decision generated much interest in Ireland as there is little case law here concerning unregistered design rights and the interpretation of the Regulation.

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world’s first recorded patent in 1449

Boehringer Ingelheim Pharmaceuticals filed a patent application titled "Pharmaceutical composition". The invention relates to a paediatric suspension of nevirapine hemihydrate. The application was filed with a total of six claims and upon its examination, the examiner raised objections on the grounds of non-patentability and definitiveness of the claims. The applicant, in compliance with the objections, then amended the claims.